Temporal Optic Disc Microvasculature Dropout in Glaucoma.


Journal

Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701

Informations de publication

Date de publication:
01 08 2023
Historique:
medline: 7 8 2023
pubmed: 4 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

To assess the clinical characteristics of focal temporal optic disc microvasculature dropout (MvD-D) in primary open-angle glaucoma (POAG) patients. One hundred and eighty-seven eyes of 187 POAG patients having MvD-D on Swept-Source optical coherence tomography angiography (SS-OCTA) were enrolled. Three groups were categorized according to the presence of temporal MvD-D within the upper and lower 45° of the fovea-Bruch's membrane (BM) opening axis: focal temporal MvD-D (Group 1, isolated focal temporal MvD-D; 44 eyes), supero/inferotemporal MvD-D (Group 2, MvD-D only in superotemporal or inferotemporal sector; 78 eyes), and diffuse temporal MvD-D (Group 3, MvD-D spanning ≥ 2 consecutive sectors, at least one of which being temporal sector; 65 eyes). Group 1 had a significantly longer axial length and β-zone parapapillary atrophy without BM. There also was a larger horizontal tilt angle and ovality index than the other two groups (P < 0.001). Group 1 had a significantly thinner retinal nerve fiber layer (RNFL) in the temporal sector than did Group 2 (P < 0.001), despite similar thicknesses in all other areas (P > 0.05). Group 3 had significantly worse visual field mean deviation and thinner RNFL than the other two groups in all areas other than the nasal, temporal, and superotemporal sectors (P < 0.05). Focal temporal MvD-D detected by SS-OCTA was associated with a longer axial length and related subsequent morphological changes of the optic disc and parapapillary area. This suggests that stretching of the optic disc consequent on axial elongation may lead to absence of temporal optic disc microvasculature.

Identifiants

pubmed: 37540177
pii: 2791374
doi: 10.1167/iovs.64.11.6
pmc: PMC10408767
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

6

Subventions

Organisme : NEI NIH HHS
ID : R01 EY029058
Pays : United States

Références

Sci Rep. 2018 Jan 18;8(1):1121
pubmed: 29348471
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1995-2004
pubmed: 29677362
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3907-13
pubmed: 27472076
Ophthalmology. 2013 Sep;120(9):1790-7
pubmed: 23672970
Am J Ophthalmol. 2020 Oct;218:105-119
pubmed: 32445702
Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4927-35
pubmed: 26225633
J Glaucoma. 2018 Nov;27(11):1032-1035
pubmed: 30161079
Ophthalmology. 2018 Aug;125(8):1215-1223
pubmed: 29550000
Ophthalmology. 2016 Dec;123(12):2509-2518
pubmed: 27769587
Sci Rep. 2021 Jul 26;11(1):15181
pubmed: 34312474
Int J Retina Vitreous. 2017 May 15;3:13
pubmed: 28515959
Ophthalmology. 2014 Jan;121(1):110-118
pubmed: 24144452
Invest Ophthalmol Vis Sci. 2014 Nov 25;56(1):156-63
pubmed: 25425302
Am J Ophthalmol. 2011 Jul;152(1):87-95.e1
pubmed: 21570046
Ophthalmology. 2012 Jan;119(1):21-6.e1-3
pubmed: 21978594
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3694-3701
pubmed: 30029256
Ophthalmology. 2006 Feb;113(2):285-93
pubmed: 16406542
Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;213(1):33-41
pubmed: 6906144
Ophthalmology. 2018 Apr;125(4):588-596
pubmed: 29224927
Am J Ophthalmol. 1976 Aug;82(2):165-74
pubmed: 821347
Am J Ophthalmol. 2013 Oct;156(4):737-44
pubmed: 23891337
Ophthalmology. 2016 Nov;123(11):2309-2317
pubmed: 27592175
Eye Vis (Lond). 2020 Sep 02;7:45
pubmed: 32905133
Br J Ophthalmol. 1969 Nov;53(11):721-48
pubmed: 4982590
Am J Ophthalmol. 2020 Oct;218:17-27
pubmed: 32413411
Eye (Lond). 2010 May;24(5):857-63
pubmed: 19680281
Am J Ophthalmol. 2013 Aug;156(2):218-227.e2
pubmed: 23768651
Am J Ophthalmol. 1995 Jul;120(1):92-102
pubmed: 7611333
Br J Ophthalmol. 2020 Mar;104(3):398-403
pubmed: 31097439
Am J Ophthalmol. 2022 Apr;236:261-270
pubmed: 34740630
Surv Ophthalmol. 1994 Jul-Aug;39(1):23-42
pubmed: 7974188
Am J Ophthalmol. 2019 Apr;200:65-75
pubmed: 30578786
Arch Ophthalmol. 2012 May;130(5):552-9
pubmed: 22232364
Ophthalmology. 2012 Sep;119(9):1844-51
pubmed: 22595297
Jpn J Ophthalmol. 2013 Jan;57(1):34-40
pubmed: 23070687
Am J Ophthalmol. 2018 Jun;190:34-49
pubmed: 29559412
Ophthalmology. 2017 Nov;124(11):1600-1611
pubmed: 28551164
Invest Ophthalmol Vis Sci. 2012 Sep 21;53(10):6472-8
pubmed: 22915038
PLoS One. 2018 Aug 7;13(8):e0201729
pubmed: 30086177
Am J Ophthalmol. 2020 Sep;217:287-296
pubmed: 32387433
Arch Ophthalmol. 2009 Sep;127(9):1136-45
pubmed: 19752422
JAMA. 2014 May 14;311(18):1901-11
pubmed: 24825645
PLoS One. 2014 Dec 22;9(12):e115313
pubmed: 25531656
Invest Ophthalmol Vis Sci. 2021 May 3;62(6):14
pubmed: 33984121
Ophthalmology. 2018 Aug;125(8):1224-1233
pubmed: 29544962
JAMA Ophthalmol. 2019 Jul 1;137(7):810-816
pubmed: 31120486
Surv Ophthalmol. 1994 May;38 Suppl:S3-6
pubmed: 7940146
Ophthalmology. 2014 May;121(5):1013-9
pubmed: 24507857
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):17
pubmed: 32176268
Am J Ophthalmol. 2021 Jul;227:154-165
pubmed: 33631124
Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4106-4113
pubmed: 28828482
J Glaucoma. 2019 Apr;28(4):341-346
pubmed: 30624389
Cleve Clin J Med. 2017 Sep;84(9 Suppl 2):e20-e25
pubmed: 28937359
Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4614-4621
pubmed: 30242362
Am J Ophthalmol. 2018 Apr;188:141-154
pubmed: 29428454
Sci Rep. 2021 Apr 23;11(1):8854
pubmed: 33893383
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1499-1505
pubmed: 28273316
Ophthalmology. 2010 Dec;117(12):2337-44
pubmed: 20678802

Auteurs

Yeon Ju Lim (YJ)

Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.

Jong Wook Bang (JW)

Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.

Robert N Weinreb (RN)

Hamilton Glaucoma Center, Shiley Eye Institute, and the Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States.

Linda M Zangwill (LM)

Hamilton Glaucoma Center, Shiley Eye Institute, and the Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States.

Min Hee Suh (MH)

Department of Ophthalmology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, South Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH